After nine years of collaboration with Classys in Australia and New Zealand, Cryomed Aesthetics has announced that they have decided to part ways as of 2nd April, 2025, as their business directions have evolved.
In a statement, Krystian Szuba, General Manager – Cryomed Aesthetics, said, “Cryomed Aesthetics has proudly played a key role in the success of Classys portfolio across the ANZ market — with standout devices such as the Ultraformer III, Ultraformer MPT, Secret RF, Curas and more.”
“At Cryomed, our priority has always been building strong, long-term relationships with our clinic partners. That commitment remains unchanged. We will continue to bring you world-class aesthetic solutions, backed by our 360-degree approach – from expert servicing and competitive consumables to locally tailored clinical education and a strong network of experts.”
“While this change will bring an update to our product offering, the incredible Cryomed team and the high level of service you’ve come to expect will stay the same. We’re excited for what’s ahead and look forward to continuing to grow with you in this vibrant industry we all love.”
“Our vision at Cryomed, has always been to look forward to the possibilities within the Aesthetics industry, and we’re excited for what’s next at Cryomed. Stay tuned – we’ll have more to share shortly.”
About Cryomed Aesthetics
EBOS Group Limited, trading as Cryomed Aesthetics, is a leading provider of aesthetic healthcare devices, medical-grade cosmeceuticals and injectables across Australia and New Zealand. Based in Sydney with offices in Melbourne and Auckland, Cryomed Aesthetics is at the forefront of cutting-edge medical aesthetic technology and is a significant technology partner with many successful medical and aesthetic clinics.
